At the board meeting of the company held on April 26, 2018 the board of directors of QuiaPEG resolved, based on its authorization, to issue 6 000 000 warrants without consideration to the Dutch investment group, Nyenburgh Holding B.V. Each warrants provides entitlement to subscription of 1 new share in QuiaPEG with a quotient value of SEK 0.9, which means that the share capital can increase by a maximum of SEK 5 400 000 upon full exercise of the warrants through subscription of a maximum of 6 000 000 new shares. The warrants may be exercised for subscription of shares in the Company during the period from and including the day of issue of the warrants up to and including April 30, 2021. The subscription rate per share shall amount to SEK 3,50. The issue of the warrants is now registered.


The shareholders of QuiaPEG Pharmaceuticals Holding AB (publ) have held an extraordinaryshareholders’meeting on June 29, 2018.The shareholders’ meeting resolved to, among othersthings, in accordance with the board ofdirectors’proposal, introduce an incentive program by way of issue of a maximum of 1 000 000 warrants to the wholly-owned subsidiary QuiaPEG Pharmaceuticals AB and to authorize the transfer of such warrants to management and others key personnel in the company and its subsidiary. The warrants are issued without consideration.


The Shareholders of QuiaPEG Pharmaceuticals Holding AB (publ) have held an Annual General Meeting on June 18, 2018.


The shareholders of QuiaPEG Pharmaceuticals Holding AB, org.nr 556658-0196, are hereby given notice to attend the Annual General Meeting to be held on June 29, 2018 10:00 a.m. at MAQS Advokatbyrå, Mäster Samuelsgatan 20 in Stockholm. Registration to the annual general meeting starts at 09:30 a.m.

QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 54 Uppsala
+46 (0) 70 693 12 53

User terms & privacy policy
Send a message